Medical devices

Northwell hospitals target pulmonary embolisms

Southside Hospital is now busting up blood clots with new tech that promises to shorten treatment time and reduce potential complications. Joining several sister hospitals throughout the Northwell Health system, the Bay Shore facility is now packing the EkoSonic Endovascular System, flagship product of the Washington State-based Ekos Corp. and the only FDA-approved endovascular device – denoting surgical procedures that insert catheters through the skin to treat blood disorders – targeting pulmonary embolisms. Those lung-based…


Canon USA pumps $40M into Mass.-based biotech

By GREGORY ZELLER // Melville-based imaging giant Canon USA has reaffirmed its commitment to the healthcare sector, to the tune of $40 million. That’s how much the global imaging-solutions provider has dropped on T2 Biosystems, a Massachusetts firm specializing in innovative diagnostics. Canon USA announced Thursday that is has purchased enough stock – at $6.56 per share – to take roughly 20 percent ownership of T2 Biosystems. Maryland-based Canon U.S. Life Sciences Inc., a wholly…


Economic development with surgical precision

By GREGORY ZELLER // With design in its DNA, MIDI Medical Product Development has a long commercialization history. With its new Innovation Center, the veteran Smithtown maker is focused squarely on Long Island’s future. Two months after cutting the ribbon on its new 6,500-square-foot headquarters and Innovation Center – a buzzing design and manufacturing hub staffed by 30 MIDI engineers, software developers, industrial designers and user-interface experts – the 44-year-old company is expanding its own…


SynchroPET gets an A in U of Buffalo testing

Stony Brook-based SynchroPET has taken another step toward unprecedented, simultaneous PET/MRI imaging. By placing a PET camera into the bore of an existing MRI machine – that’s the chamber where the patient slides in – SynchroPET achieved “another significant milestone on its quest to disrupt the medical imaging industry,” the company said in a statement. PET systems track gamma rays emitted by tiny injected tracers, then use computers to construct 3D images of the body’s…


Henry Shein ‘pleased’ with Q1’s 10% sales jump

They’re off to the races once again at Henry Schein Inc., where healthy increases in net sales and net income highlighted a strong first quarter. Coming off a stellar 2015, the aggressively expanding Melville-based healthcare products distributor reported net sales of $2.7 billion for the quarter ended March 26, an increase of 10.1 percent over net sales reported in 1Q 2015. The sales spike came despite a 1.9 percent decline in foreign currency exchange rates,…


Have a lumbar sciatica? You want the O-Arm

By GREGORY ZELLER // The first Long Island spinal surgeries incorporating a state-of-the-art “intraoperative surgical imaging system” have been successfully completed, with many more to come. In early March, Robert Kerr, chief of neurosurgery at Northwell Health’s Huntington Hospital, performed a lumbar sciatica procedure on a 48-year-old Northport resident using the O-Arm, a real-time 3D-imaging system produced by Irish medical-tech giant Medtronic. About a week later, Kerr performed a lateral mass screw and rod fixation…


At Northwell, a $100K slam dunk

By GREGORY ZELLER // Fans of the NCAA Men’s Basketball Tournament will help dictate the course of scientific research at Northwell Health. A new multimedia contest featuring television commercials and online voting will pit three Northwell Health-based medical innovations against each other, with $100,000 in health system research support up for grabs. The voting is actually open to all, though the TV campaign will heavily target fans tuning into the NCAA tournament. Through deal with…


For allergy sufferers, treatment is now at hand

By GREGORY ZELLER // Most allergy-related emergencies stem from some simple problem. When a patient can’t find his auto-injector, or doesn’t know how to use it, or the medication inside is expired, bad things happen. Collectively called anaphylaxis, allergic reactions can be life-threatening events with a frighteningly fast onset. But modern medical science can stand toe-to-toe – if patients know how to store, access and apply the proper tools, according to Dr. Gregory Puglisi, a…


Henry Schein shines in Q4, full year

An impressive rise in adjusted earnings per share highlighted 2015 fourth-quarter and year-end financials released Wednesday by Henry Schein Inc. For 4Q 2015, which ended Dec. 31, the global healthcare-products provider reported EPS of $1.67, a 7.1 percent year-over-year jump. The aggressively expanding Melville company credited the quarterly increase – and a year-end EPS of $5.96, up 9.6 percent from 2014’s per-share earnings – to strong revenues across its Dental, Medical, Animal Health and Technology…


Northwell readies move into 3D markets

By GREGORY ZELLER // With 3D printing rapidly redefining what’s medically feasible, the Northwell Health system is rushing to study the commercial possibilities. Not only are scientists at the Feinstein Institute for Medical Research – the health system’s R&D arm – riding the next wave of 3D printing’s medical applications, but Northwell itself is looking at ways to take the emerging science to market. Specifically, Northwell Ventures, the system’s commercialization office, is considering two 3D-printing verticals,…


Schein inks distribution deal for diabetes products

A new U.S. distribution agreement puts a Long Island healthcare-products stalwart in the thick of the fight against type 2 diabetes. Global medical-technology provider Medtronic has selected Henry Schein Medical, a subsidiary of Melville-based Henry Schein Inc., as its exclusive distributor of selected diabetes products to primary-care physicians in the United States. The deal, terms undisclosed, will introduce Schein customers to Medtronic’s cutting-edge solutions for people with Diabetes mellitus type 2, the most common form…


Henry Schein posts leap in net profits

Melville-based Henry Schein reported an 11.3 percent jump in net profits for the third quarter on Wednesday. And that despite an $8.4 million pre-tax restructuring charge. Net profits were $127.7 million, or $1.52 a share, up from $114.8 million ($1.34 a share) in the third quarter of 2014. Sales climbed 2.4 percent to $2.69 billion from $2.62 billion. Excluding the restructuring charges as well as a one-time tax benefit, net profits would have been $130.6 million ($1.55…


Schein acquires Italian dental firm

Another day, another acquisition of a company with annual revenues in the $40 million range. Just one day after announcing the acquisition of a majority share of Pennsylvania-based animal-health software maker Vetstreet, Melville healthcare products distributor Henry Schein Inc. has announced the acquisition of a 90 percent ownership share of Dental Trey, an Italian distributor of dental consumables and equipment. The deal is expected to close by the end of the year, according to Henry…


Applause for Steven Patrikis’ 3-D Tetra-Hand

By GREGORY ZELLER // NYIT junior Steven Patrikis, on course for a bachelor’s degree in mechanical engineering next fall, already knows what he wants to do professionally, even if he’s not sure what he wants to study in graduate school. Patrikis plans to turn his love of electronics and robotics into a career spent helping others. His focus at the moment: folks missing a hand. Using 3-D printers and other tools inside NYIT-Old Westbury’s Entrepreneurship…


Chembio lands $2.1M grant from Microsoft’s Allen

Medford-based Chembio Diagnostics has been awarded a $2.1 million grant from Microsoft co-founder Paul G. Allen to develop a speedier test for fevers, including Ebola and malaria. The one-year grant, from a $100 million Allen-funded Ebola eradication program, will cover development costs of a one-shot blood test for malaria, dengue, Ebola, Lassa, Marburg and chikungunya. Chembio chief executive John J. Sperzel said the six illnesses are characterized by a high-grade fever and can be fatal when…